| 2025-08-05 | +22.3% | earnings | Seeking Alpha | InfuSystem raises adjusted EBITDA margin outlook to 20%+ as margin expansion continues amid revenue guide revision |
| 2025-08-05 | +22.3% | earnings | Seeking Alpha | InfuSystem Holdings, Inc. (INFU) Q2 2025 Earnings Call Transcript |
| 2025-08-05 | +22.3% | earnings | Seeking Alpha | InfuSystem GAAP EPS of $0.12, revenue of $36M |
| 2025-08-05 | +22.3% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2021-08-12 | -20.9% | legal | SEC EDGAR | INFU 8-K: 2.02 and (SEC Filing) |
| 2022-05-05 | +19.6% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2023-03-15 | -18.3% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2024-11-09 | +15.9% | earnings | Seeking Alpha | InfuSystem Holdings, Inc. (INFU) Q3 2024 Earnings Call Transcript |
| 2025-03-04 | -14.1% | earnings | Seeking Alpha | InfuSystem Holdings, Inc. (INFU) Q4 2024 Earnings Call Transcript |
| 2025-03-04 | -14.1% | earnings | Seeking Alpha | InfuSystem GAAP EPS of $0.04 misses by $0.03, revenue of $33.85M misses by $1.05M |
| 2025-03-04 | -14.1% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2022-04-28 | +13.3% | legal | SEC EDGAR | INFU 8-K: 1.01 and 7.01 (SEC Filing) |
| 2024-09-26 | +13.0% | news | Seeking Alpha | InfuSystem a new buy at B Riley on infusion pump business |
| 2025-05-08 | +12.5% | earnings | Seeking Alpha | InfuSystem beats top-line and bottom-line estimates; reaffirms FY25 outlook |
| 2025-05-08 | +12.5% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2026-02-24 | +11.4% | earnings | Moby | InfuSystem Holdings, Inc. Q4 2025 Earnings Call Summary |
| 2026-02-24 | +11.4% | earnings | Zacks | InfuSystems Holdings, Inc. (INFU) Q4 Earnings Beat Estimates |
| 2026-02-24 | +11.4% | news | Business Wire | InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025 |
| 2026-02-24 | +11.4% | earnings | Seeking Alpha | InfuSystem outlines 6% to 8% revenue growth for 2026 following contract restructuring |
| 2026-02-24 | +11.4% | earnings | Seeking Alpha | InfuSystem Holdings, Inc. (INFU) Q4 2025 Earnings Call Transcript |
| 2026-02-24 | +11.4% | earnings | Seeking Alpha | InfuSystem reports mixed Q4 results; introduces FY26 outlook |
| 2026-02-24 | +11.4% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2026-02-24 | +11.4% | news | Meyka | Roth Capital Maintains Buy on INFU InfuSystem Holdings, Inc. Feb 24 2026 - Meyka |
| 2021-11-15 | +11.0% | legal | SEC EDGAR | INFU 8-K: 2.02 and (SEC Filing) |
| 2024-11-07 | +10.7% | earnings | Seeking Alpha | InfuSystem GAAP EPS of $0.08 beats by $0.02, revenue of $35.3M beats by $0.82M |
| 2024-11-07 | +10.7% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2024-05-09 | -9.0% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2023-11-07 | -9.0% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2026-02-23 | +8.5% | earnings | Seeking Alpha | InfuSystem Q4 Earnings Preview |
| 2025-11-03 | -7.7% | earnings | Seeking Alpha | InfuSystem Q3 2025 Earnings Preview |
| 2024-01-12 | -7.4% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2025-06-03 | +6.9% | legal | SEC EDGAR | INFU 8-K: 3.03, 5.02and5.03 (SEC Filing) |
| 2023-03-28 | -5.9% | legal | SEC EDGAR | INFU 8-K: 5.02 (SEC Filing) |
| 2023-04-29 | -5.7% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for InfuSystems Holdings (INFU) - Zacks Investment Research |
| 2026-03-02 | +5.5% | executive | Stock Titan | InfuSystem (INFU) CFO adds 2,064 shares in open-market purchase - Stock Titan |
| 2024-03-08 | +5.0% | legal | SEC EDGAR | INFU 8-K: 1.01 and 5.02 (SEC Filing) |
| 2023-08-03 | +4.5% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2024-11-18 | +4.3% | legal | SEC EDGAR | INFU 8-K: 5.02 (SEC Filing) |
| 2026-03-16 | +4.3% | news | Business Wire | InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026 |
| 2026-03-16 | +4.3% | news | Stock Titan | Outpatient care firm InfuSystem heads to investor ROTH conference - Stock Titan |
| 2026-03-16 | +4.3% | news | Stock Titan | InfuSystem (INFU) executives set for 38th Annual ROTH investor meetings - Stock Titan |
| 2025-08-26 | +4.1% | news | Seeking Alpha | InfuSystem: A New Sheriff In Town |
| 2025-08-26 | +4.1% | news | Seeking Alpha | InfuSystem: A New Sheriff In Town (NYSE:INFU) - Seeking Alpha |
| 2025-02-10 | +4.0% | news | Seeking Alpha | InfuSystem Set For Strong Year |
| 2025-11-10 | +3.5% | news | Seeking Alpha | InfuSystem Set To Be A Cash Cow In 2026 |
| 2025-11-10 | +3.5% | news | Seeking Alpha | InfuSystem Holdings: Riding On The Oncology Market Opportunity |
| 2025-11-10 | +3.5% | news | Seeking Alpha | InfuSystem Stock: Margin Expansion And Growth Strategy To Drive Strong Gains (NYSE:INFU) - Seeking Alpha |
| 2025-11-10 | +3.5% | news | Seeking Alpha | InfuSystem Holdings: Riding On The Oncology Market Opportunity (NYSE:INFU) - Seeking Alpha |
| 2025-11-10 | +3.5% | news | Seeking Alpha | InfuSystem Set To Be A Cash Cow In 2026 (NYSE:INFU) - Seeking Alpha |
| 2026-02-26 | +3.5% | earnings | GuruFocus.com | InfuSystems Holdings Inc (INFU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... |
| 2026-02-26 | +3.5% | analyst | The Globe and Mail | Analysts Are Bullish on Top Healthcare Stocks: InfuSystem Holdings (INFU), Jazz Pharmaceuticals (JAZZ) - The Globe and Mail |
| 2025-11-11 | +3.1% | news | Seeking Alpha | InfuSystem Stock: Margin Expansion And Growth Strategy To Drive Strong Gains |
| 2022-11-08 | +3.0% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2025-11-04 | -3.0% | earnings | Seeking Alpha | InfuSystem reaffirms 6%–8% revenue growth and 20%+ EBITDA margin outlook as profitability strategy advances |
| 2025-11-04 | -3.0% | earnings | Seeking Alpha | InfuSystem Holdings, Inc. (INFU) Q3 2025 Earnings Call Transcript |
| 2025-11-04 | -3.0% | earnings | Seeking Alpha | InfuSystem reports mixed Q3 results; reaffirms FY25 outlook |
| 2025-11-04 | -3.0% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2026-04-12 | +2.8% | news | Seeking Alpha | InfuSystem: Expecting Strong Stock Gains In 2026 |
| 2026-04-11 | +2.8% | news | Seeking Alpha | InfuSystem: Expecting Strong Stock Gains In 2026 (NYSE:INFU) - Seeking Alpha |
| 2024-05-20 | +2.6% | news | Seeking Alpha | InfuSystem announces $20M stock repurchase program |
| 2023-05-04 | +2.3% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2026-04-19 | +2.2% | news | The Chronicle-Journal | InfuSystems Holdings, Inc. Common Stock (NY: INFU - The Chronicle-Journal |
| 2026-01-30 | +2.2% | legal | Seeking Alpha | InfuSystem: Regulatory Backed Market Catalyst |
| 2026-01-30 | +2.2% | legal | Seeking Alpha | InfuSystem: Regulatory Backed Market Catalyst (NYSE:INFU) - Seeking Alpha |
| 2026-02-19 | +2.1% | earnings | Zacks | ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates |
| 2026-02-17 | +2.1% | news | Business Wire | InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 |
| 2025-06-22 | -2.1% | news | Seeking Alpha | InfuSystem: Investments Are Starting To Pay Off |
| 2025-04-01 | -2.0% | legal | SEC EDGAR | INFU 8-K: 5.02 (SEC Filing) |
| 2024-08-26 | -1.9% | legal | Seeking Alpha | InfuSystem Set For Strong Second Half |
| 2023-05-25 | -1.6% | legal | SEC EDGAR | INFU 8-K: 5.02 (SEC Filing) |
| 2026-04-15 | +1.4% | news | Minichart | InfuSystem Holdings, Inc. (INFU) - Minichart |
| 2024-03-14 | -1.3% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2025-05-16 | +1.3% | news | Intellectia AI | INFU Forecast — Price Prediction for 2026. Should I Buy INFU? - Intellectia AI |
| 2025-05-10 | -1.3% | earnings | Seeking Alpha | InfuSystem Holdings, Inc. (INFU) Q1 2025 Earnings Call Transcript |
| 2026-02-05 | -1.2% | earnings | Zacks | Prestige Consumer Healthcare (PBH) Q3 Earnings Lag Estimates |
| 2025-07-17 | -0.9% | legal | SEC EDGAR | INFU 8-K: 1.01 and 2.03 (SEC Filing) |
| 2023-05-02 | +0.9% | legal | SEC EDGAR | INFU 8-K: 1.01 and 2.03 (SEC Filing) |
| 2025-05-20 | +0.9% | legal | SEC EDGAR | INFU 8-K: 5.02 and 5.07 (SEC Filing) |
| 2024-08-08 | +0.7% | earnings | Seeking Alpha | InfuSystem GAAP EPS of $0.03, revenue of $33.7M |
| 2024-08-08 | +0.7% | legal | SEC EDGAR | INFU 8-K: 2.02 (SEC Filing) |
| 2022-09-23 | -0.2% | legal | SEC EDGAR | INFU 8-K: 5.02 (SEC Filing) |
| 2024-08-10 | -0.1% | earnings | Seeking Alpha | InfuSystem Holdings, Inc. (INFU) Q2 2024 Earnings Call Transcript |
| 2025-12-10 | -0.0% | news | Investing.com | InfuSystem stock rises after pumps added to CMS payment list - Investing.com |